Central Laboratory, First Affiliated Hospital, Dalian Medical University, Dalian 116021, China; Pharmacy Department & Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, 201399, China; The Institute of Integrative Medicine, Dalian Medical University, Dalian 116021, China.
The Institute for Translational Nanomedicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
J Colloid Interface Sci. 2022 May 15;614:436-450. doi: 10.1016/j.jcis.2022.01.131. Epub 2022 Jan 24.
Although low-temperature photothermal therapy (PTT) can sensitize tumors to immune checkpoint inhibition, its efficacy is still restricted in the deep and internal tumors without enough oxygen and lymphocytic infiltration. Non-oxygen-dependent alkyl radicals have been demonstrated to synergistically enhance PTT through up-regulating lipid peroxidation and reactive oxygen species (ROS). Herein, an innovative strategy based on alkyl radicals to augment immunogenetic cell death (ICD) caused by mild PTT was proposed to improve poor efficacy of immunotherapy, which composed of a photothermal material of Chinse ink, an azo-initiator of 2,2-azobis[2-(2-imidazoline-2-acyl)propane]dihydrochloride (AIPH) and a PD-L1 inhibitor of HY19991 (HY). Upon near-infrared-II laser irradiation, low-temperature (<45℃) stimulation induced a high expression of immune checkpoint receptor (PD-L1) in tumors and triggered a large amount alkyl radicals generated by AIPH. Significantly, the alkyl radicals augmented the ICD and increased the recruitment of tumor-infiltrating lymphocytes against tumors after transformation of the immunologically cold tumor microenvironment into hot by mild PTT. The released HY further enhanced the immunotherapy effect by blocking the binding of activated T lymphocytes and PD-L1. In vivo studies exhibited that the all-in-one hydrogel with synergistic mechanisms had an extraordinary ability to reverse the immunosuppressive microenvironment, stimulate innate and adaptive immune responses to eliminate tumors and prevent metastasis.
虽然低温光热治疗(PTT)可以使肿瘤对免疫检查点抑制敏感,但由于深部和内部肿瘤缺氧和淋巴细胞浸润不足,其疗效仍受到限制。已经证明非氧依赖性烷基自由基可以通过上调脂质过氧化和活性氧(ROS)来协同增强 PTT。在此,提出了一种基于烷基自由基的创新策略,通过温和的 PTT 增强免疫遗传细胞死亡(ICD),以改善免疫疗法的疗效不佳,该策略由中国墨水的光热材料、2,2-偶氮双[2-(2-咪唑啉-2-酰基)丙烷]二盐酸盐(AIPH)的偶氮引发剂和 PD-L1 抑制剂 HY19991(HY)组成。近红外-II 激光照射后,低温(<45°C)刺激在肿瘤中诱导高表达免疫检查点受体(PD-L1),并引发大量由 AIPH 产生的烷基自由基。重要的是,烷基自由基增强了 ICD,并通过温和 PTT 将免疫冷肿瘤微环境转化为热环境,增加了对肿瘤的浸润性淋巴细胞的募集。释放的 HY 通过阻断激活的 T 淋巴细胞和 PD-L1 的结合进一步增强了免疫治疗效果。体内研究表明,具有协同机制的一体化水凝胶具有非凡的能力来逆转免疫抑制微环境,刺激先天和适应性免疫反应以消除肿瘤并预防转移。